
All News




The financial consequences of becoming disabled can be devastating if pharmacists lack proper financial planning.

Studying individuals’ genomes can help influence how different medications work for a patient, avoid harmful adverse drug reactions, and allow scientists to develop personalized medicines for patients with a wide range of diseases and disorders.

Top articles of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Fingolimod treats relapsing forms of multiple sclerosis in adult patients.

As more vaping cases are reported, patients may desire answers from their trusted providers.

A new method of targeted radiation therapy sends alpha-emitting particles directly to stroma cells in pancreatic cancer tissue.

The OTC Guide survey will be open for pharmacists to participate from Nov. 15, 2019, to March 1, 2020.

Top news of the day from across the health care landscape.

Men with breast cancer had higher mortality than women regardless of cancer type, treatment, and access to care.

Louisiana, Nevada, Texas rank highest in flu activity for the month of November.

Amneal has begun commercialization activities for the generic versions of sildenafil for oral suspension 10 mg/ml and aminocaproic acid tablets USP, 500 mg.

The approval for the first generic sucralfate oral suspension is 1 of the 15 complex products the manufacturer expects to launch over an 18- to 24-month period.

Understanding adherence patterns is the first step to combat the HIV epidemic in this population.

Top news of the day from across the health care landscape.

Psychological factors such as anxiety and depression can directly influence a patient’s experience with cancer-related pain.

Approval was based on results from the phase 3 Impower130 study, which showed atezolizumab in combination with chemotherapy increased overall survival in participants compared with chemotherapy alone.

Emmes, a scientific research company, will support the development of a universal influenza vaccine that could provide longer-lasting protection than the current vaccines available.

Top news of the day from across the health care landscape.

Social interactions between hypothetical health care providers and patients have the power to influence a patient’s perception on the efficacy of a treatment.

The contrast agent is newly indicated to opacify the left ventricular chamber, and to improve the delineation of the left ventricular endocardial border in pediatric patients with suboptimal echocardiograms.

Officials from the FDA have approved methotrexate (RediTrex, Cumberland Pharmaceuticals) as an injection for the treatment of adult and pediatric patients with rheumatoid arthritis.

Researchers showed that treating multiple myeloma cells with gamma-secretase inhibitors allowed CAR T-cells to more accurately treat cancer tumors.

Staying on top of oral hygiene may be connected to a lower risk of atrial fibrillation and heart failure.

It is currently uncertain to what extent interleukin inhibitors may increase the risk of serious infections and cancer in patients being treated for rheumatic diseases.

Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss how Specialty Pharmacists can drive the data standardization conversation during the NASP Annual Meeting in Washington, DC.

Since 2005, the CDC has enforced National Influenza Vaccination Week to emphasize the importance of continuing flu vaccination even through the winter months. Although it is the holiday season, the CDC and other organizations want to remind the general public that it is never a bad time to get your flu vaccine. Sam Nass, PharmD, MBS and Walgreens Immunizations Manager weighed in on the subject in an interview with Pharmacy Times®.






